Novo Nordisk’s diabetes drug Ozempic may reduce the risk of opioid overdose, study finds
Related media - Breaking news Recent research suggests that Ozempic, a diabetes treatment developed by Novo Nordisk, may play an unexpected role in reducing the risk of opioid overdose. The…










